Part 2/11:
The Frankenfish is a bioengineered Atlantic salmon that grows to market size in half the time of conventional salmon. This rapid growth results from the insertion of genes from other species—specifically, a growth hormone from chinook salmon and a hormone from the ocean pout—combined through genetic modification. The outcome is a fish that needs approximately 25% less feed and can be farmed more efficiently, reducing resource consumption.
Recently, the first shipment of AquAdvantage salmon eggs arrived at AquaBounty's facility in Indiana, marking a historic milestone: this fish is the first genetically modified animal approved for human consumption in the United States. The journey from innovation to market has spanned over three decades, filled with intense debates and regulatory hurdles.